CRISPR Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,416 | 0.00402% |
Individual Insiders | 485,977 | 0.573% |
General Public | 30,466,292 | 35.9% |
Institutions | 53,927,406 | 63.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,157,028 | US$438.3m | -4.44% | 3.55% | |||
6,420,736 | US$345.0m | 0.92% | 0.02% | |||
4,475,532 | US$240.5m | -1.02% | 0.02% | |||
3,268,785 | US$175.6m | -3% | 0.07% | |||
2,516,486 | US$135.2m | -7.25% | no data | |||
1,839,029 | US$98.8m | -10.6% | 0.01% | |||
1,753,497 | US$94.2m | -6.97% | no data | |||
1,590,651 | US$85.5m | 3.37% | no data | |||
1,587,854 | US$85.3m | 0% | 4.87% | |||
1,067,351 | US$57.3m | -2.65% | 0.08% | |||
1,048,951 | US$56.4m | 0% | 16.99% | |||
900,400 | US$48.4m | 0.22% | 0.57% | |||
883,729 | US$47.5m | 3.98% | no data | |||
779,454 | US$41.9m | -11.4% | 0.01% | |||
726,887 | US$39.1m | 0% | 0.16% | |||
699,332 | US$37.6m | -5.79% | 0.03% | |||
653,023 | US$35.1m | 0% | 0.01% | |||
617,586 | US$33.2m | -13.7% | no data | |||
549,007 | US$29.5m | 19.7% | 0.01% | |||
508,100 | US$27.3m | 0% | 0.08% | |||
498,558 | US$26.8m | 0% | 8.61% | |||
475,008 | US$25.5m | 280% | 0.03% | |||
422,763 | US$22.7m | -4.15% | 0.01% | |||
408,122 | US$21.9m | 5.36% | no data | |||
406,855 | US$21.9m | -5.44% | no data |